fraud
CEO of PixarBio Corporation sentenced to prison for defrauding investors
February 19, 2020Research and Development Biopharmaceuticals, CEO, FDA, corruption, fraud, investors
Frank Reynolds, the CEO of Boston based PixarBio Corporation, was sentenced to seven years in prison for defrauding investors and …
Teva settles $135 million dollar fraud case over Medicaid price inflation
January 14, 2019Sales and Marketing court, fraud, law, lawsuit, pharma, price fxing
Israeli multinational Teva Pharmaceuticals has agreed to pay $135 million after being accused of fraudulently inflating wholesale prices that went …
Digital system may prevent £300m prescription fraud losses for NHS by 2020
October 15, 2018Sales and Marketing NHS, fraud, government, prescription fraud, uk politics
The British government are launching a new digitised system aimed at cracking down on prescription fraud in the NHS. However …
Indian biotech owner detained in Dubai over £550m fraud allegations
August 16, 2018Medical Communications Dubai, Gujurat, India, Sterling Biotech, UAE, fraud
Indian businessman Nitin Sandesara, the owner of the Gujarat-based pharmaceutical company Sterling Biotech, has been detained in Dubai in relation …
Former Valeant executive and Philidor CEO charged with fraud
November 18, 2016Medical Communications, Sales and Marketing Philidor, Valeant, Valeant Pharmaceuticals, fraud
Gary Tanner, former executive, and Andrew Davenport, ex-CEO of Philidor, have been arrested and charged with fraud. Preet Bharara, US …
Hard times continue for Valeant as ex-CEO investigated for fraud
November 1, 2016Manufacturing and Production CEO, Valeant, Valeant Pharmaceuticals, accounting, fraud
Valeant Pharmaceuticals continues to have a tough time after Bloomsberg broke the story of how former CEO J. Michael Pearson …
Former shareholders sue Valeant, alleging “vast fraud”
August 19, 2016Medical Communications, Sales and Marketing Valeant, fraud, lawsuit, t rowe price
Valeant Pharmaceuticals has confirmed that it is being sued by one its former largest shareholders, T Rowe Price, who claim …
Pfizer to pay $784.6 million fine due to Wyeth Medicaid fraud
April 28, 2016Medical Communications, Sales and Marketing False Claims Act, Medicaid, Pfizer, US, Wyeth, department, fraud, insurer, justice
Pfizer has agreed to pay $784.6 million in a settlement with the US Department of Justice, relating to false and …
Top five pharma controversies of 2015 (so far)
November 20, 2015Medical Communications, Sales and Marketing AstraZeneca, Martin Shkreli, Philidore, Takeda, Turing Pharmaceutical, Valeant, Warner Chilcott, controversies, fraud, reputation, tax avoidance, turing
5. AstraZeneca forced to deny tax avoidance allegations
Former Deputy Attorney General called in to advise Valeant after fraud allegations
November 2, 2015Medical Communications, Sales and Marketing Mark Filip, Philidor, Valeant, fraud
Valeant Pharmaceuticals’ board of directors has appointed former Deputy Attorney General of the United States Mark Filip to advise the …
Allergan subsidiary president arrested on kickback charges
November 2, 2015Sales and Marketing Allergan, US District Court, Warner Chilcott, fraud, healthcare fraud
Allergan subsidiary Warner Chilcott will plead guilty to a US felony charge of healthcare fraud, and settle a case of …
Novartis faces data fraud charges in Japan
July 3, 2014Medical Communications, Sales and Marketing Diovan, Japan, Novartis, data, fraud, heart, valsartan
Novartis is facing criminal charges in Japan over the alleged falsifying of data for its once big-selling heart drug Diovan. …
Novartis back under microscope
June 23, 2014Medical Communications, Sales and Marketing Italy, Novartis, avastin, fraud, influenza, vaccines
Novartis is under the microscope yet again in Italy, with police visiting the company’s sites at Siena and Origgio in …
GSK ruling: Another failing, but will the industry learn?
July 4, 2012Medical Communications, Sales and Marketing GSK, fraud, legal, marketing fine
Court papers surrounding GSK’s $3 billion fraud charge make for grim reading, and further damages an industry that already struggles …
GSK’s Stiefel accused of shares fraud
December 13, 2011Sales and Marketing GSK, SEC, Stiefel, fraud
The US financial regulator has charged a subsidiary of GlaxoSmithKline with defrauding staff by buying back shares from them at …
